APA (7th ed.) Citation

Quidde, J., & Kripp, M. (2017). Baseline and on-treatment markers determining prognosis of first-line chemotherapy in combination with bevacizumab in patients with metastatic colorectal cancer. Oncology research and treatment, 40(1/2), . https://doi.org/10.1159/000454774

Chicago Style (17th ed.) Citation

Quidde, Julia, and Melanie Kripp. "Baseline and On-treatment Markers Determining Prognosis of First-line Chemotherapy in Combination with Bevacizumab in Patients with Metastatic Colorectal Cancer." Oncology Research and Treatment 40, no. 1/2 (2017). https://doi.org/10.1159/000454774.

MLA (9th ed.) Citation

Quidde, Julia, and Melanie Kripp. "Baseline and On-treatment Markers Determining Prognosis of First-line Chemotherapy in Combination with Bevacizumab in Patients with Metastatic Colorectal Cancer." Oncology Research and Treatment, vol. 40, no. 1/2, 2017, https://doi.org/10.1159/000454774.